Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.
The purpose of this study is to elucidate the pharmacokinetics and the blood-brain barrier penetration of the elemene.
Cancer
blood and cerebrospinal fluid concentration, 0，0.25，0.5，1，1.5，2，3，3.5，4，6，8，12 hours post dose
The purpose of this study is to elucidate the pharmacokinetics and the blood-brain barrier penetration of the elemene.